Paying for TRUVADA

If you’re concerned about how you will pay for your HIV therapy, start by talking to your healthcare provider. He or she may be able to help you apply for assistance.

If you have insurance

Gilead HIV Co-pay Assistance Coupon Card
Gilead Co-Pay Assistance Program You may be able to save on the co-pay for your TRUVADA prescription, with a GILEAD HIV Co-pay Assistance Coupon Card. Call 1-877-505-6986 for more information and to see if you are eligible.*

*The program is subject to change or cancellation at any time.

If you don’t have insurance

Gilead U.S. Advancing Access® Program
This program provides assistance to patients in the United States who do not have insurance or who need financial assistance. As part of this program, Gilead provides assistance for people who are eligible and who cannot afford to pay for TRUVADA. To learn about eligibility, contact Advancing Access® at 1-800-226-2056 between 9:00 a.m. and 8:00 p.m. (Eastern).

Partnership for Prescription Assistance (PPA) Program
This program is designed to help uninsured Americans get the prescription medicines they need at no or low cost. To find out if you qualify, here’s what to do:

  1. Call toll-free 1-888-4PPA-NOW (1-888-477-2669).
  2. Know the names of the medicines you take.
  3. A trained specialist will answer your questions and help you apply.
You can visit the PPA Web site at www.pparx.org.

Help may also be available through:

Please see the full Prescribing Information including Medication Guide with important warnings

Close the layer

You Are Now Leaving

By following this link, you are now leaving www.TRUVADA.com.
These sites are not controlled by Gilead Sciences, Inc. Gilead Sciences, Inc. is not responsible for their content or your use of them.

IMPORTANT SAFETY INFORMATION

The most serious possible side effects of TRUVADA (emtricitabine/tenofovir disoproxil fumarate) are:

  • Lactic acidosis (a buildup of acid in the blood), which is a serious, sometimes fatal, medical emergency. Symptoms of lactic acidosis include weakness, unusual muscle pain, trouble breathing, nausea, vomiting, a fast or irregular heartbeat, and/or feeling cold, dizzy or lightheaded
  • Serious liver problems (hepatotoxicity), with liver enlargement (hepatomegaly), and fat in the liver (steatosis). Symptoms of liver problems include your skin or the whites of your eyes turning yellow (jaundice), dark colored urine, light colored stools, lack of appetite, nausea, and/or pain in your lower stomach area
    • You may be more likely to get lactic acidosis or serious liver problems if you are female, very overweight (obese), or have been taking TRUVADA or similar medicines for a long time. In some cases, these serious conditions have led to death. Call your healthcare provider right away if you have any symptoms of these conditions
  • If you have HIV-1 and hepatitis B virus (HBV) and stop taking TRUVADA, your hepatitis may suddenly get worse. Your healthcare provider will monitor your condition for several months

If you are an HIV-1 negative adult, your healthcare provider may prescribe TRUVADA to help reduce the risk of you getting HIV-1 infection through sex if you are at high risk (a man who has sex with men who are at high risk for getting HIV-1 through sex or if you are in a heterosexual couple where one partner is HIV-1 positive and the other is not). This use of TRUVADA is called Pre-exposure Prophylaxis or PrEP.

  • If you are prescribed TRUVADA for PrEP the most important information you need to know is that you must be HIV-1 negative
    • Before taking TRUVADA to help prevent getting HIV-1 infection through sex you must be tested to be completely sure you do not have HIV. You will also need to be tested regularly (every 3 months) to confirm you remain HIV-1 negative. This is because TRUVADA alone is not a complete treatment for HIV-1 infection and you may develop resistance which will make your infection harder to treat
    • You must always practice safer sex. Use a condom, know your HIV status and that of your partner(s), get tested for other sexually transmitted infections (like syphilis and gonorrhea) and take action to limit your contact with body fluids
    • If you have symptoms like fever, feeling tired, sweating a lot (especially at night), rash, vomiting, diarrhea, joint or muscle aches, headache, sore throat and/or enlarged lymph nodes (especially in your neck or groin), and you may have been recently exposed to HIV (i.e., had unprotected sex) these may be symptoms of HIV infection, so tell your healthcare provider immediately
  • Take your dose of TRUVADA every day, as prescribed by your healthcare provider and see your healthcare provider regularly
  • Do not take TRUVADA to prevent sexually acquiring HIV-infection if you are HIV positive or do not know your status
  • See the Medication Guide for further information about using TRUVADA for PrEP

Do not take TRUVADA if you also take products containing emtricitabine or tenofovir disoproxil fumarate (a/k/a tenofovir DF) [ATRIPLA (efavirenz/emtricitabine/tenofovir DF), COMPLERA (emtricitabine/rilpivirine/tenofovir DF), VIREAD (tenofovir DF), EMTRIVA (emtricitabine)]; or products containing lamivudine [Combivir (lamivudine/zidovudine), Epivir or Epivir-HBV (lamivudine), Epzicom (abacavir sulfate/lamivudine), or Trizivir (abacavir sulfate/lamivudine/zidovudine)] because these medicines contain the same or similar active ingredients. TRUVADA should also not be used with HEPSERA (adefovir dipivoxil).

Other serious side effects include:

  • New or worsening kidney problems: If you have had kidney problems or take other medicines that can cause kidney problems, your healthcare provider should do regular blood tests to check your kidneys
  • Bone problems: Lab tests show changes in the bones of patients treated with VIREAD (tenofovir DF), a medicine in TRUVADA. Some patients treated with VIREAD developed softening or thinning of the bones which could lead to fractures
  • Changes in body fat: Changes in the distribution of body fat have been seen in some people taking TRUVADA and other anti-HIV-1 medicines. The long term health effect of this is not known
  • Symptoms of inflammation: In some patients with advanced HIV-1 infection (AIDS), symptoms of inflammation from previous infections may occur soon after anti-HIV treatment is started. If you notice any symptoms of infection, tell your healthcare provider right away

Common side effects include:

  • The most common side effects of the medicines in TRUVADA when taken with other anti-HIV-1 medicines are diarrhea, dizziness, nausea, headache, fatigue, abnormal dreams, sleeping problems, rash, and depression.
  • Stomach area (abdomen) pain, headache and decreased weight have been reported in adults taking TRUVADA alone for pre-exposure prophylaxis.

Before taking TRUVADA to help treat HIV-1 infection, tell your healthcare provider if you:

  • Are pregnant or plan to become pregnant: It is not known if TRUVADA can harm your unborn baby, so speak to your doctor about the risk of using TRUVADA while pregnant
  • Are breastfeeding: Women with HIV should not breastfeed, because HIV can be passed through breast milk to the baby. Also, TRUVADA can pass into your breast milk, and it is not known if this will harm your baby. Talk to your healthcare provider about the best way to feed your baby
  • Have or had liver, kidney, or bone problems, including hepatitis virus infection or if you have ever been on dialysis

Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins, and herbal supplements. Your healthcare provider may need to follow you more closely or adjust your therapy if you take Videx EC (didanosine), Reyataz (atazanavir sulfate), or Kaletra (lopinavir/ritonavir) with TRUVADA to treat HIV-1 infection.

These are not all the side effects of TRUVADA. If you have any questions about side effects, talk to your healthcare provider. Please see the full Prescribing Information including Medication Guide for more information about using TRUVADA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch, or call 1-800-FDA-1088.

Close the layer

You Are Now Leaving

By following this link, you are now leaving www.TRUVADA.com.
These sites are not controlled by Gilead Sciences, Inc. Gilead Sciences, Inc. is not responsible for their content or your use of them.